Literature DB >> 22416790

A cohort evaluation of the laryngeal mask airway-Supreme™ in children.

Narasimhan Jagannathan1, Lisa E Sohn, Edwina Chang, Amod Sawardekar.   

Abstract

OBJECTIVES: To assess the clinical performance of the laryngeal mask airway-Supreme in children. AIM: The purpose of this prospective audit was to evaluate the feasibility of the laryngeal mask airway-Supreme in clinical practice and generate data for future comparison trials.
BACKGROUND: The laryngeal mask airway-Supreme is a new second-generation supraglottic airway that was recently released in limited pediatric sizes (sizes 1, 2).
METHODS: One hundred children, ASA I-III, newborn to 16 years of age, and undergoing various procedures requiring a size 1, 2, or 3 laryngeal mask airway-Supreme were studied. Assessments included insertion success rates, airway leak pressures, success of gastric tube insertion, quality of airway, and perioperative complications.
RESULTS: The first-time insertion success rate was 97%, with an overall insertion success rate of 100%. The mean initial airway leak pressure for all patients was 22.3 ± 6.6 cm H(2) O. Gastric tube placement was possible in 98% of patients. Complications were noted in six patients: coughing or laryngospasm (n = 3), sore throat (n = 1), and dysphonia (n = 2).
CONCLUSIONS: The laryngeal mask airway-Supreme was inserted with a high degree of success on the first attempt by clinicians with limited prior experience with the device. It was effectively used for a variety of procedures in children undergoing spontaneous and mechanical ventilation with minimal complications. The leak pressures demonstrated in this study, along with access for gastric decompression, suggest that the laryngeal mask airway-Supreme may be an effective device for positive pressure ventilation in children.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22416790     DOI: 10.1111/j.1460-9592.2012.03832.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  10 in total

1.  An evaluation of the I-gel supraglottic airway in 70 pediatric patients.

Authors:  Tze Yeng Yeoh; Koo Boon Chan; Lynn S H Yeo; Eugene H C Liu; Terry L T Pan
Journal:  J Anesth       Date:  2014-09-12       Impact factor: 2.078

2.  Comparison of Size 2 LMA-ProSeal™ and LMA-Supreme™ in Spontaneously Breathing Children: a Randomised Clinical Trial.

Authors:  Zehra İpek Arslan; Canan Balcı; Duygu Akalın Oysu; Mehmet Yılmaz; Necla Gürbüz; Zekeriya Ilce
Journal:  Balkan Med J       Date:  2013-03-01       Impact factor: 2.021

3.  A comparison of i-gel™ and LMA Supreme™ in anesthetized and paralyzed children.

Authors:  Hyuk Kim; Ji Yeon Lee; Seung Yoon Lee; Sang Yoong Park; Seung Cheol Lee; Chan Jong Chung
Journal:  Korean J Anesthesiol       Date:  2014-11-26

4.  A clinical trial evaluating the laryngeal mask airway-Supreme in obese children during general anesthesia.

Authors:  Yue Tian; Xiu-Ying Wu; Lu Li; Ling Ma; Yun-Feng Li
Journal:  Arch Med Sci       Date:  2016-12-19       Impact factor: 3.318

5.  Comparing i-gel and Ambu AuraOnce laryngeal mask airway in pediatric patients.

Authors:  Gui-Zhen Yang; Fu-Shan Xue; Hui-Xian Li; Ya-Yang Liu
Journal:  Saudi Med J       Date:  2017-12       Impact factor: 1.484

Review 6.  Small is the new big: An overview of newer supraglottic airways for children.

Authors:  Rakhee Goyal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Oct-Dec

7.  A comparison of i-gel™ and Laryngeal Mask Airway Supreme™ during general anesthesia in infants.

Authors:  Yoon Chan Lee; Kyoung Seop Yoon; Sang Yoong Park; So Ron Choi; Chan Jong Chung
Journal:  Korean J Anesthesiol       Date:  2017-08-14

8.  Observation of ventilation effects of I-gel™, Supreme™ and Ambu AuraOnce™ with respiratory dynamics monitoring in small children.

Authors:  Zhiqing Gu; Quanying Jin; Junjun Liu; Lianhua Chen
Journal:  J Clin Monit Comput       Date:  2016-08-04       Impact factor: 2.502

9.  A cohort evaluation of clinical use and performance characteristics of Ambu® AuraGain™: A prospective observational study.

Authors:  Devangi A Parikh; Ruchi A Jain; Smita S Lele; Bharati A Tendolkar
Journal:  Indian J Anaesth       Date:  2017-08

10.  Ambu AuraOnce versus i-gel laryngeal mask airway in infants and children undergoing surgical procedures. A randomized controlled trial.

Authors:  Abdulrahman M Alzahem; Mansoor Aqil; Tariq A Alzahrani; Ayman H Aljazaeri
Journal:  Saudi Med J       Date:  2017-05       Impact factor: 1.484

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.